Document Type : Letter to Editor
Authors
1 Department of Clinical Pharmacy, National Children’s Medical Center, Children’s Hospital of Fudan University, Shanghai, China
2 NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China
Abstract
Keywords
Dear Editor,
China is one of the world’s largest producers of active pharmaceutical ingredients and generic drugs.1 In 2021, the Chinese government established a comprehensive evaluation system that defines the value of pharmaceuticals across six dimensions, including safety, efficacy, cost-effectiveness, appropriateness, accessibility, and innovation.2 Policy-makers and clinical specialists consider six criteria and their relevant sub-criteria in assessing the overall performance of drugs. Firstly, safety aspects encompass adverse drug reactions causing systemic damage and the incidence rate of individual adverse reactions. ...(Read more...)
)
